February 8, 2025

Ron Finklestien

“Join the Fight: CDLX Investors Can Take the Lead in Cardlytics, Inc. Securities Fraud Case with Schall Law Firm”

Investors Urged to Join Class Action Against Cardlytics, Inc. (CDLX)

LOS ANGELES, Feb. 6, 2025 /PRNewswire/ — The Schall Law Firm, a leading firm specializing in shareholder litigation, announces a class action lawsuit against Cardlytics, Inc. (“Cardlytics” or “the Company”) CDLX for breaching securities laws from the Securities Exchange Act of 1934 and related SEC rules.

(PRNewsfoto/The Schall Law Firm)

Investors who bought Cardlytics stocks between March 14, 2024 and August 7, 2024 (the “Class Period”) are encouraged to reach out to the firm by March 25, 2025.

If you are a shareholder facing losses, click here to participate.

For more information, contact Brian Schall of the Schall Law Firm at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or call 310-301-3335. You can also visit our website at www.schallfirm.com, or email us at [email protected].

Currently, the class in this case has not been certified. Until that happens, individuals are not represented by an attorney. Should you choose not to take any action, you will remain an absent class member.

The complaint alleges that Cardlytics provided false and misleading information to investors. Although the Company reported increased consumer incentives due to rising engagement, it failed to boost its billings in line with this growth. As a result, Cardlytics faced potential slowdowns in revenue growth. The changes in their Ads Decision Engine led to budget and billing shortfalls, further misleading the public. This means that when the truth about Cardlytics emerged, investors suffered losses.

Join the case to recover your losses.

The Schall Law Firm serves investors globally, focusing on securities class action lawsuits and protecting shareholder rights.

This notice may qualify as Attorney Advertising in certain jurisdictions under applicable regulations.

CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/cdlx-investors-have-opportunity-to-lead-cardlytics-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302370571.html

SOURCE The Schall Law Firm

Market News and Data brought to you by Benzinga APIs


Subscribe to Pivot and Flow Daily